Immunic
IMUX
$0.91
Share price
3.44%
Change (1 day)
-34.23%
Change (1 year)
Categories
Earnings for Immunic (IMUX)
Earnings in 2024 (TTM): -$98.06 Million USD
According to Immunic's latest financial reports the company's current earnings are N/A. , an increase over its 2023 earnings that were of -$99.23 Million USD. The earnings displayed on this page is the company's Pretax Income.
Earnings history for Immunic from 2013 to 2024
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2024  | -$98.06 Million | -1.18% |
| 2023 | -$99.23 Million | 14.68% |
| 2022 | -$86.52 Million | -5.62% |
| 2021 | -$91.67 Million | 87.18% |
| 2020 | -$48.98 Million | 32.24% |
| 2019 | -$37.04 Million | -9.25% |
| 2018 | -$40.81 Million | -22.5% |
| 2017 | -$52.66 Million | 27.6% |
| 2016 | -$41.27 Million | -20.82% |
| 2015 | -$52.12 Million | 9.34% |
| 2014 | -$47.67 Million | 33.05% |
| 2013 | -$35.83 Million |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 | -$0.15 Billion | 45.73% | 🇺🇸 USA |